-
1
-
-
0036023452
-
Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells
-
Wu M H, Yan B F, Rod H and Dolan M E 2002 Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells Clin. Cancer Res. 8 2696-700 (Pubitemid 34856359)
-
(2002)
Clinical Cancer Research
, vol.8
, Issue.8
, pp. 2696-2700
-
-
Wu, M.H.1
Yan, B.2
Humerickhouse, R.3
Dolan, M.E.4
-
2
-
-
0346392116
-
Development and characterization of a novel liposome-based formulation of SN-38
-
DOI 10.1016/j.ijpharm.2003.10.015
-
Zhang J A, Tong X, Manjeet P, Ma L, Sydney U, Shahid A and Imran A 2004 Development and characterization of a novel liposome-based formulation of SN-38 Int. J. Pharm. 270 93-107 (Pubitemid 38077091)
-
(2004)
International Journal of Pharmaceutics
, vol.270
, Issue.1-2
, pp. 93-107
-
-
Zhang, J.A.1
Xuan, T.2
Parmar, M.3
Ma, L.4
Ugwu, S.5
Ali, S.6
Ahmad, I.7
-
3
-
-
0141955909
-
Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors
-
Joshua W, Rachael L, Robert S, Marek R, Rachel L, Rajan R and Evan U 2003 Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors J. Control. Release 91 167-72
-
(2003)
J. Control. Release
, vol.91
, pp. 167-172
-
-
Joshua, W.1
Rachael, L.2
Robert, S.3
Marek, R.4
Rachel, L.5
Rajan, R.6
Evan, U.7
-
4
-
-
0032905667
-
Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin
-
Nadia Z S, Raymond E, Cvitkovic E and Goldwasser F 1999 Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin Clin. Cancer Res. 5 1189-96 (Pubitemid 29233237)
-
(1999)
Clinical Cancer Research
, vol.5
, Issue.5
, pp. 1189-1196
-
-
Zeghari-Squalli, N.1
Raymond, E.2
Cvitkovic, E.3
Goldwasser, F.4
-
5
-
-
0034892379
-
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)
-
Mathijssen R H J, Alphen R J A, Verweij J, Walter J L, Nooter K, Stoter G and Sparreboom A 2001 Clinical pharmacokinetics and metabolism of irinotecan (CPT-11) Clin. Cancer Res. 7 2182-94 (Pubitemid 32751614)
-
(2001)
Clinical Cancer Research
, vol.7
, Issue.8
, pp. 2182-2194
-
-
Mathijssen, R.H.J.1
Van Alphen, R.J.2
Verweij, J.3
Loos, W.J.4
Nooter, K.5
Stoter, G.6
Sparreboom, A.7
-
6
-
-
27744580052
-
Liposomalization of SN-38 as active metabolite of CPT-11
-
Yasuyuki S, Hiroyuki T and Takashi S 2005 Liposomalization of SN-38 as active metabolite of CPT-11 J. Control. Release 108 453-9
-
(2005)
J. Control. Release
, vol.108
, pp. 453-459
-
-
Yasuyuki, S.1
Hiroyuki, T.2
Takashi, S.3
-
7
-
-
67651180631
-
Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice
-
Fatemeh A, Anahita F, Farnaz E and Rassoul D 2009 Preparation of pegylated nano-liposomal formulation containing SN-38: in vitro characterization and in vivo biodistribution in mice Acta Pharm. 59 133-44
-
(2009)
Acta Pharm.
, vol.59
, pp. 133-144
-
-
Fatemeh, A.1
Anahita, F.2
Farnaz, E.3
Rassoul, D.4
-
8
-
-
33750549679
-
Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors
-
Fumiaki K, Masayuki K and Takahito N 2006 Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors Cancer Res. 66 10048-56
-
(2006)
Cancer Res.
, vol.66
, pp. 10048-10056
-
-
Fumiaki, K.1
Masayuki, K.2
Takahito, N.3
-
9
-
-
57249084773
-
Polymeric micellar delivery systems in oncology Japan
-
Yasuhiro M 2008 Polymeric micellar delivery systems in oncology Japan. J. Clin. Oncol. 38 793-802
-
(2008)
J. Clin. Oncol.
, vol.38
, pp. 793-802
-
-
Yasuhiro, M.1
-
10
-
-
77952691329
-
Preparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT-29 cell lines
-
Pedram E, Rassoul D, Abolghasem S, Mahmoud R J, Ali R N, Ebrahim A, Mazda R M and Fatemeh A 2010 Preparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT-29 cell lines Nanomed.: Nanotechnol., Biol., Med. 6 478-85
-
(2010)
Nanomed.: Nanotechnol., Biol., Med.
, vol.6
, pp. 478-485
-
-
Pedram, E.1
Rassoul, D.2
Abolghasem, S.3
Mahmoud, R.J.4
Ali, R.N.5
Ebrahim, A.6
Mazda, R.M.7
Fatemeh, A.8
-
11
-
-
44749084015
-
Potential oral delivery of 7-Ethyl-10-hydroxy-camptothecin (SN-38) using poly(amidoamine) dendrimers
-
Rohit B K, Peter S and Hamidreza G 2008 Potential oral delivery of 7-Ethyl-10-hydroxy-camptothecin (SN-38) using poly(amidoamine) dendrimers Pharm. Res. 25 1723-9
-
(2008)
Pharm. Res.
, vol.25
, pp. 1723-1729
-
-
Rohit, B.K.1
Peter, S.2
Hamidreza, G.3
-
12
-
-
77958156329
-
Carboxyl-terminated PAMAM-SN38 conjugates: Synthesis, characterization, and in vitro evaluation 2010
-
Nirmalkumar V, Abhijit R, Alexander M and Hamidreza G 2010 Carboxyl-terminated PAMAM-SN38 conjugates: synthesis, characterization, and in vitro evaluation 2010 Bioconjug. Chem. 21 1804-10
-
(2010)
Bioconjug. Chem.
, vol.21
, pp. 1804-1810
-
-
Nirmalkumar, V.1
Abhijit, R.2
Alexander, M.3
Hamidreza, G.4
-
13
-
-
79955051898
-
G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity
-
Deborah S G, Nirmalkumar V, Peter W S and Hamidreza G 2011 G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity J. Control. Release 150 318-25
-
(2011)
J. Control. Release
, vol.150
, pp. 318-325
-
-
Deborah, S.G.1
Nirmalkumar, V.2
Peter, W.S.3
Hamidreza, G.4
-
14
-
-
67650450638
-
Folate-mediated chondroitin sulfate-Pluronic 127 nanogels as a drug carrier
-
Huang S J, Sun T H, Feng T H, Sung K H, Lui W L and Wang L F 2009 Folate-mediated chondroitin sulfate-Pluronic 127 nanogels as a drug carrier Eur. J. Pharm. Sci. 38 64-73
-
(2009)
Eur. J. Pharm. Sci.
, vol.38
, pp. 64-73
-
-
Huang, S.J.1
Sun, T.H.2
Feng, T.H.3
Sung, K.H.4
Lui, W.L.5
Wang, L.F.6
-
15
-
-
67349137876
-
Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: Formulation, optimization and in vitro characterization
-
Zhang W, Junguo H, Shi Y, Ya J L, Wu J, Xianyi S and Xiao L F 2009 Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization Int. J. Pharm. 376 176-85
-
(2009)
Int. J. Pharm.
, vol.376
, pp. 176-185
-
-
Zhang, W.1
Junguo, H.2
Shi, Y.3
Ya, J.L.4
Wu, J.5
Xianyi, S.6
Xiao, L.F.7
-
16
-
-
79951576538
-
Multifunctional pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors
-
Zhang W, Shi Y, Chen Y, Ye J, Sha X and Fang X 2011 Multifunctional pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors Biomaterials 32 2894-906
-
(2011)
Biomaterials
, vol.32
, pp. 2894-2906
-
-
Zhang, W.1
Shi, Y.2
Chen, Y.3
Ye, J.4
Sha, X.5
Fang, X.6
-
17
-
-
0029980834
-
Development of amphiphilic diblock copolymers as micellar carriers of taxol
-
DOI 10.1016/0378-5173(95)04386-1
-
Zhang X, Jackson J K and Burt H M 1996 Development of amphiphilic diblock copolymers as micellar carriers of taxol Int. J. Pharm. 132 195-206 (Pubitemid 26158719)
-
(1996)
International Journal of Pharmaceutics
, vol.132
, Issue.1-2
, pp. 195-206
-
-
Zhang, X.1
Jackson, J.K.2
Burt, H.M.3
-
18
-
-
33646000852
-
HPLC method for determination of SN-38 content and SN-38 entrapment efficiency in a novel liposome-based formulation, LE-SN38
-
Tong X, Zhang J A and Imran A 2006 HPLC method for determination of SN-38 content and SN-38 entrapment efficiency in a novel liposome-based formulation, LE-SN38 J. Pharm. Biomed. Anal. 41 582-8
-
(2006)
J. Pharm. Biomed. Anal.
, vol.41
, pp. 582-588
-
-
Tong, X.1
Zhang, J.A.2
Imran, A.3
-
19
-
-
0034646825
-
Simple and rapid determination of irinotecan and its metabolite SN-38 in plasma by high-performance liquid-chromatography: Application to clinical pharmacokinetic studies
-
DOI 10.1016/S0378-4347(00)00048-7, PII S0378434700000487
-
Escoriaza J, Aldaz A, Castellanos C, Calvo E and Giráldez J 2000 Simple and rapid determination of irinotecan and its metabolite SN-38 in plasma by high-performance liquid-chromatography: application to clinical pharmacokinetic studies J. Chromatogr. B 740 159-68 (Pubitemid 30190115)
-
(2000)
Journal of Chromatography B: Biomedical Sciences and Applications
, vol.740
, Issue.2
, pp. 159-168
-
-
Escoriaza, J.1
Aldaz, A.2
Castellanos, C.3
Calvo, E.4
Giraldez, J.5
-
20
-
-
70449711530
-
Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs
-
Shin H, Alani W G, Rao D A, Rockich N C and Kwon G S 2009 Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs J. Control. Release 140 294-300
-
(2009)
J. Control. Release
, vol.140
, pp. 294-300
-
-
Shin, H.1
Alani, W.G.2
Rao, D.A.3
Rockich, N.C.4
Kwon, G.S.5
-
21
-
-
44749086918
-
Development and validation of HPLC method for the determination of tobramycin in urine samples post-inhalation using pre-column derivatisation with fluorescein isothiocyanate
-
Mashat M, Chrystyn H, Clark B J and Assi K H 2008 Development and validation of HPLC method for the determination of tobramycin in urine samples post-inhalation using pre-column derivatisation with fluorescein isothiocyanate J. Chromatogr. B 869 59-66
-
(2008)
J. Chromatogr. B
, vol.869
, pp. 59-66
-
-
Mashat, M.1
Chrystyn, H.2
Clark, B.J.3
Assi, K.H.4
-
22
-
-
0015909406
-
Relation of detergent HLB number to solubilization and stabilization of D-Alanine carboxypeptidase from Bacillus subtilis membranes
-
Jay N U and Jack L S 1973 Relation of detergent HLB number to solubilization and stabilization of D-Alanine carboxypeptidase from Bacillus subtilis membranes Proc. Natl Acad. Sci. 70 2997-3001
-
(1973)
Proc. Natl Acad. Sci.
, vol.70
, pp. 2997-3001
-
-
Jay, N.U.1
Jack, L.S.2
-
23
-
-
67650032608
-
Development of multi-Phase emulsions based on bioresorbable polymers and oily adjuvant
-
Huang M H, Huang C Y, Lien S P, Siao S Y, Chou A H, Chen H W, Liu S J, Leng C H and Chong P 2009 Development of multi-Phase emulsions based on bioresorbable polymers and oily adjuvant Pharm. Res. 26 1856-62
-
(2009)
Pharm. Res.
, vol.26
, pp. 1856-1862
-
-
Huang, M.H.1
Huang, C.Y.2
Lien, S.P.3
Siao, S.Y.4
Chou, A.H.5
Chen, H.W.6
Liu, S.J.7
Leng, C.H.8
Chong, P.9
-
24
-
-
0037309349
-
Optimal structure requirements for Pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells
-
DOI 10.1124/jpet.102.043307
-
Elena V B, Li S, Valery Y A, Donald W M and Alexander V K 2003 Optimal structure requirements for Pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells J. Pharm. Exp. Ther. 304 845-54 (Pubitemid 36152365)
-
(2003)
Journal of Pharmacology and Experimental Therapeutics
, vol.304
, Issue.2
, pp. 845-854
-
-
Batrakova, E.V.1
Li, S.2
Alakhov, V.Y.3
Miller, D.W.4
Kabanov, A.V.5
-
25
-
-
77951785011
-
Thermodynamic studies and loading of 7-Ethyl-10-hydroxycamptothecin into mesoporous silica particles MCM-41 in strongly acidic solutions
-
Rishi T, Balasubramanian S and Michalakis S 2010 Thermodynamic studies and loading of 7-Ethyl-10-hydroxycamptothecin into mesoporous silica particles MCM-41 in strongly acidic solutions J. Phys. Chem. B 114 5903-11
-
(2010)
J. Phys. Chem. B
, vol.114
, pp. 5903-5911
-
-
Rishi, T.1
Balasubramanian, S.2
Michalakis, S.3
|